Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.66 |
| ▸ | EGFR | P00533 | 4/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.46 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.46 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL28965991 | 0.96 | LMNA (0.66) | LMNASMN1; SMN2EGFRPOLBL3MBTL1 | |
| SCHEMBL28529875 | 0.96 | LMNA (0.66) | LMNASMN1; SMN2EGFRPOLBL3MBTL1 | |
| SCHEMBL30137348 | 0.96 | LMNA (0.66) | LMNASMN1; SMN2EGFRPOLBL3MBTL1 | |
| Lithium Ion SCHEMBL30137319 | 0.96 | LMNA (0.66) | LMNASMN1; SMN2EGFRPOLBL3MBTL1 | |
| SCHEMBL950218 | 0.81 | LMNA (0.73) | LMNASMN1; SMN2EGFRPOLBL3MBTL1 | |
| SCHEMBL30792459 | 0.79 | SMN1; SMN2 (1.00) | LMNASMN1; SMN2EGFRPOLBL3MBTL1 | |
| SCHEMBL29412848 | 0.79 | SMN1; SMN2 (1.00) | LMNASMN1; SMN2EGFRPOLBL3MBTL1 | |
| SCHEMBL17180592 | 0.79 | LMNA (0.70) | LMNASMN1; SMN2EGFRPOLBL3MBTL1 | |
| SCHEMBL105459 | 0.79 | SMN1; SMN2 (0.70) | LMNASMN1; SMN2EGFRPOLBL3MBTL1 | |
| SCHEMBL29799007 | 0.79 | SMN1; SMN2 (0.70) | LMNASMN1; SMN2EGFRPOLBL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115611802-B | Synthetic method of 3-acetyl-2-chloropyridine | 北京迪泰医药科技有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-115611802-A | Synthetic method of 3-acetyl-2-chloropyridine | 北京迪泰医药科技有限公司 | 2023-01-17 | — | — | CN | disclosed |
| EP-1770093-A1 | Pyrido¬2,3-d|pyrimidine derivatives as phosphodiesterase inhibitors | Roche Palo Alto LLC (US) | 2007-04-04 | — | — | EP | disclosed |
| EP-0631580-A1 | PYRIDO 2,3-d]PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1995-01-04 | — | — | EP | disclosed |
| US-5264437-A | Antiinflammatory agents, immunosuppressants or antiallergens | SYNTEX (U.S.A.) INC. (US) | 1993-11-23 | — | — | US | disclosed |
| WO-1993019068-A1 | PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1993-09-30 | — | — | WO | disclosed |